期刊文献+

Innate immunity in inflammatory bowel disease 被引量:13

Innate immunity in inflammatory bowel disease
下载PDF
导出
摘要 The human intestinal tract is home to an enormous bacterial flora. The host defense against microorganisms can be divided into innate and adaptive immunity. The former is the most immediate line of response to immunologic challenges presented by bacteria, viruses, and fungi. The mucosal immune system has evolved to balance the need to respond to pathogens while co-existing with commensal bacteria and food antigens. In inflammatory bowel disease (IBD), this hyporesponsiveness or tolerance breaks down and inflammation supervenes driven by the intestinal microbial flora. Bacteria contain compounds and are recognized by a variety of receptors, including Toll-like receptors (TLRs) and NODs (a family of intracellular bacterial sensors) and are potent stimuli of innate immune responses. Several mutations in these receptors have been associated with development of IBD. The human intestinal tract is home to an enormous bacterial flora.The host defense against microorganisms can be divided into innate and adaptive immunity The former is the most immediate line of response to immunologic challenges presented by bacteria viruses,and fungi.The mucosal immune system has evolved to balance the need to respond to pathogens while co-existing with commensal bacteria and food antigens.In inflammatory bowel disease(IBD),this hyporesponsiveness or tolerance breaks down and inflammation supervenes driven by the intestina microbial flora.Bacteria contain compounds and are recognized by a variety of receptors,including Toll-like receptors(TLRs)and NODs(a family of intracellula bacterial sensors)and are potent stimuli of innate immune responses.Several mutations in these receptors have been associated with development of IBD.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第42期5577-5580,共4页 世界胃肠病学杂志(英文版)
关键词 INNATE IMMUNITY Toll-like receptors Inflammatory bowel disease 肠炎 发病机理 先天免疫力 胞内细菌受体
  • 相关文献

参考文献1

二级参考文献10

  • 1Ahmad T,Tamboli CP,Jewell DP,Colombel JF.Clinical relevance of advances in genetics and pharmacogenetics of IBD[].Gastroenterology.2004
  • 2Torok HP,Glas J,Lohse P,Folwaczny C.Alteration of the CARD15/NOD2 gene and the impact on management and treatment of Crohn’s disease patients[].Digestive Diseases.2003
  • 3Cario E,Podosky DK.Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease[].Infection and Immunity.2000
  • 4Lorenz E,Frees KL,Schwartz DA.Determination of the TLR4 genotype using allele-specific PCR[].Biotechniques.2001
  • 5Lennard-Jones JE.Classification of inflammatory bowel disease[].Scandinavian Journal of Gastroenterology.1989
  • 6Hornef MW,Normark BH,Vandewalle A,Normark S.Intra-cellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells[].The Journal of Experimental Medicine.2003
  • 7Podolsky DK.Inflammatory bowel disease[].The New England Journal of Medicine.2002
  • 8Leong RW,Armuzzi A,Ahmad T,Wong ML,Tse P,Jewell DP,Sung JJ.NOD2/CARD15 gene polymorphisms and Crohn’s disease in the Chinese population[].Alimentary Pharmacology and Therapeutics.2003
  • 9Aldhous MC,Nimmo ER,Satsangi J.NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease[].Gut.2003
  • 10Laszlo Lakatos,Gabor Mester,Zsuzsanna Erdelyi,Mihaly Balogh,Istvan Szipocs,Gyorgy Kamaras,Peter Laszlo Lakatos.Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001[J].World Journal of Gastroenterology,2004,10(3):404-409. 被引量:17

共引文献13

同被引文献73

引证文献13

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部